Drug Withdrawn in NHS Cut Backs Made

Wed, 09 Jun 2010
Many diabetic patients face altering their medication as a pharmaceutical giant plans to withdraw a key treatment from the UK, creating extra work for the NHS when hundreds of jobs are about to be axed.

Doctors are confirming that the removal of insulin Mixtard 30 which diabetics have relied upon for over a decade, is going to cause significant upheaval for patients as well as the health service.

Adult and child diabetics use Mixtard 30 widely.

A clinician said the removal of the product would cause chaos.

Mixtard 30 falls into a category of insulin which is cheaper for the NHS to buy. However, according to recent Scottish research, it is just as effective as the more expensive, newer, generation of diabetic drugs.

Earlier in 2010, the Scottish health service stated that hundreds of thousands of pounds would be saved should more patients use the older form of insulin.

The Danish drugs firm, Novo Nordisk, withdrawing Mixtard 30 is going to mean fewer options for clinicians who wish to adhere to such advice and save the NHS money.

There are almost 230,000 people in Scotland who have diabetes and 2.5 million diabetics in the UK. Type one diabetics and some Type two diabetics rely on insulin injections to keep the problem under check .

Link to this page

Copy and Paste the following HTML into your page.